Subscribe To
Harmony Biosciences Reports First Quarter 2023 Financial Results and Business Updates
WAKIX® (pitolisant) Net Revenue Increased ~40% Year-over-Year to $119.1 Million for First Quarter 2023 Average Number of Patients on WAKIX Increased ~1,200 Year-over-Year to ~5,100 for First Quarter 2023 Exited First Quarter 2023 With ~5,200 Patients on WAKIX WAKIX Surpassed $1 Billion in Cumulative Net Revenue Since Launch Anticipate Topline Data in Fourth Quarter 2023 […] The post Harmony Biosciences Reports First Quarter 2023 Financial Results and Business Updates appeared first on ForexTV...
Read More
Posted: May 2 2023, 11:30
Author Name: forextv
Views: 110517